Ledger.Open graph →
SEC Form D · filed April 29, 2021

Bilayer Therapeutics, Inc

Offering
$3.6M
Sold
$2.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Robert A. Langer · Cambridge, MADirectorJoshua A. Korzenik · Cambridge, MADirectorCarlo T. Giovanni · Cambridge, MADirectorThomas A. Collet · Cambridge, MAExec · DirectorRobert A. Langer · Cambridge, MADirectorCarlo T. Giovanni · Cambridge, MADirectorJoshua A. Korzenik · Cambridge, MADirectorThomas A. Collet · Cambridge, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗